New product: Astra Zeneca COVID-19 Vaccine ((ChAdOx1 S [recombinant]) Temporary Authorisation

An SPC and PIL has now been published for this vaccine. As with any new medicine, healthcare professionals are asked to report any suspected adverse reactions.

Source:

electronic Medicines compendium